Overview
Prognostic indicators for patients with Candida spp. bloodstream infections
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Current Appointments & Affiliations
Professor in Medicine
·
2022 - Present
Medicine, Infectious Diseases,
Medicine
Recent Publications
Building upon the core elements of antifungal stewardship: practical recommendations for effective antifungal stewardship in resource-limited settings.
Journal Article Expert Rev Anti Infect Ther · April 10, 2025 INTRODUCTION: Despite the crucial importance of effective AFS in resource-limited settings, such settings remain comparatively underserved and underrepresented in terms of resource-setting-specific guidance and research. Further practical contextualization ... Full text Link to item CiteCurrent Antifungals and the Developing Pipeline.
Journal Article Infect Dis Clin North Am · March 2025 Prevention and management of invasive fungal infections is challenging due to the complexity of at-risk patient population, high morbidity and mortality of these infections, and pharmacologic aspects of available antifungal agents. While there has been sub ... Full text Link to item CiteAssociation Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive Aspergillosis.
Journal Article Open Forum Infect Dis · January 2025 BACKGROUND: Early antifungal initiation in invasive aspergillosis (IA) is recommended. Changing antifungals occurs for a myriad of reasons but associated costs are unclear. METHODS: US claims data for adults admitted for IA were identified from 10/1/2015 t ... Full text Link to item CiteRecent Grants
Tri-Institutional Molecular Mycology and Pathogenesis Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Systems Biology for Infectious Diseases
ResearchPrincipal Investigator · Awarded by The Lundquist Institute · 2023 - 2028Host directed medicine in invasive fungal infection - HDM-FUN
Clinical TrialCo Investigator · Awarded by European Union · 2020 - 2026View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2007
M.H.S.
Campbell University ·
1997
Pharm.D.
Duke University, School of Medicine ·
1992
B.S.